Description
Product Overview
DSIP, or Delta Sleep-Inducing Peptide, is a short nine-amino-acid peptide originally identified during experimental research into sleep-associated biological processes.
Although its name originates from early observations involving slow-wave sleep, DSIP has subsequently been investigated across a broader range of neuropeptide and regulatory signalling models. Its precise biological role remains an active and historically debated area of research.
Pronoia supplies DSIP as a 10mg lyophilised research material for controlled laboratory investigation, with batch traceability and supporting documentation available.
Product Specification
Product: DSIP
Full name: Delta Sleep-Inducing Peptide
Specification: 10mg
Peptide length: 9 amino acids
Material class: Research peptide
Form: Lyophilised solid
Minimum purity standard: ≥98%
Batch traceability: Maintained
SKU: PB-DSIP-10
Quality, Testing & Traceability
Pronoia maintains batch traceability for DSIP and retains supporting analytical documentation for the supplied research material.
Independent analytical testing supports product quality assessment, with batch-specific documentation used to record identity, purity and consistency.
Where a specific analytical method or result is reported for an individual batch, the corresponding Certificate of Analysis should be treated as the authoritative reference.
Certificate of Analysis (COA) and Safety Data Sheet (SDS) documentation are available to support laboratory records and material assessment.
Research Context
DSIP was originally identified and named during experimental studies investigating sleep-associated signalling. Subsequent research has explored the peptide across a wider range of neural and regulatory biological models.
Research areas associated with DSIP include:
- Neuropeptide signalling mechanisms
- Sleep-related and rhythmic biological processes
- Neural regulatory pathways
- Neuroendocrine signalling interactions
- Peptide metabolism and stability
- Structure–function research involving short-chain peptides
Early experimental work associated DSIP with changes in slow-wave sleep, while later investigations have produced a more complex and sometimes inconsistent picture of its biological activity. Its precise endogenous role and mechanism therefore remain unresolved.
This makes DSIP particularly relevant as a research material for investigating peptide signalling and regulatory mechanisms rather than as a compound with a single established biological function.
Storage & Handling
DSIP is supplied in lyophilised form to support stability during storage and laboratory handling.
The product should be maintained under the temperature-controlled conditions specified by Pronoia and the applicable batch documentation, protected from unnecessary heat, moisture and repeated environmental exposure.
Researchers should follow appropriate laboratory procedures when preparing or handling the material and use validated protocols appropriate to their individual experimental requirements.
Where batch-specific storage instructions are supplied, those instructions should take precedence.
Delivery & Documentation
DSIP is supplied through Pronoia’s tracked UK delivery service using its established research-product fulfilment process.
Batch traceability is maintained, with Certificate of Analysis (COA) and Safety Data Sheet (SDS) documentation available to support laboratory records and material assessment.
Current dispatch availability and applicable delivery conditions are displayed directly on the product page and remain subject to Pronoia’s delivery terms.
Research Use Statement
DSIP supplied by Pronoia Bio is intended strictly for controlled laboratory research and experimental use.
It is not supplied for human or veterinary use and should not be treated as a medicine or consumer healthcare product.
Purchasers are responsible for ensuring that the material is used appropriately within their research environment and in accordance with applicable requirements.
